Paramyxovirus reverse genetics is coming of age

Microbiology and Immunology

Volumn 43, Issue 7, 1999, Pages 613-624

  Nagai, Yoshiyuki ^a,b   Kato, Atsushi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Accessory proteins; Gene therapy; M protein; Paramyxovirus; Reverse genetics; Sendai virus; Vaccine development; Vector

Indexed keywords

GENE PRODUCT; M PROTEIN; RIBONUCLEOPROTEIN; VACCINE; VIRUS VECTOR;

ARENAVIRUS; BUNYAVIRUS; CISTRON; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; MEASLES VIRUS; MONONEGAVIRALES; ORTHOMYXOVIRUS; PARAMYXOVIRUS; PROTEIN EXPRESSION; REVIEW; SENDAI VIRUS; VIRAL GENETICS; VIRUS GENOME;

ARENAVIRUS; MEASLES VIRUS; MONONEGAVIRALES; ORTHOBUNYAVIRUS; ORTHOMYXOVIRIDAE; PARAMYXOVIRIDAE; RNA VIRUSES; SENDAI VIRUS;

EID: 0032770049     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1999.tb02448.x     Document Type: Review

References (74)

1. Baron, M.D., and Barrett, T. 1997. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71: 1265-1271.
2. Billeter, M.A., and Cattaneo, R. 1991. Molecular biology of defective measles virus persisting in the human central nervous system, p.323-345. In Kingsbury, D.W. (ed), The paramyxoviruses, Plenum Press, New York.
3. Boyer, J.C., and Haenni, A.L. 1994. Infectious transcripts and cDNA clones of RNA viruses. Virology 198: 415-426.
4. Bridgen, A., and Elliott, R.M. 1996. Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl. Acad. Sci. U.S.A. 93: 15400-15404.
5. Buchholz, U.J., Finke, S., and Conzelmann, K.-L. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in acts as a functional BRSV genome promoter. J. Virol. 73: 251-259.
6. Bukreyev, A., Camargo, E., and Collins, P.L. 1996. Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene. J. Virol. 70: 6634-6641.
7. Cathomen, T., Mrkic, B., Spehner, D., Drillien, R., Naef, R., Pavlovic, J., Aguzzi, A., Billeter, M.A., and Cattaneo, R. 1998. A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J. 17: 3899-3908.
8. Cattaneo, R., Kaelin, K., Baczko, K., and Billeter, M.A. 1989. Measles virus editing provides an additional cysteinerich protein. Cell 56: 759-764.
9. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D., and Baltimore, D. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391: 397-401.
10. Collins, P., Chanock, R., and MacIntosh, K. 1996. Parainfluenza viruses, p.1205-1241. In Fields, B.N. et al (eds), Virology, 3rd ed, Raven Press, New York.
11. Collins, P.L., Hill, M.G., Camargo, E., Grosfeld, H., Chanock, R.M., and Murphy, B.R. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U.S.A. 92: 11563-11567.
12. Collins, P.L., Whitehead, S.S., Burkreyev, A., Feams, R., Teng, M.N., Juhasz, K., Chanock, R.M., and Murphy, B.R. 1998. Rational design of a live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res. in press.
13. Curran, J., and Kolakofsky, D. 1987. Identification of an additional Sendai virus non-structural protein encoded by the P/C mRNA. J. Gen. Virol. 68: 2515-2519.
14. Curran, J., and Kolakofsky, D. 1988. Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J. 7: 245-251.
15. Curran, J., and Kolakofsky, D. 1989. Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J. 8: 521-526.
16. Delenda, C., Hausmann, S., Garcin, D., and Kolakofsky, D. 1997. Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228: 55-62.
17. Delenda, C., Taylor, G., Hausmann, S., Garcin, D., and Kolakofsky, D. 1998. Sendai viruses with altered P, V, and W protein expression. Virology 242: 327-337.
18. Durbin, A.P., Hall, S.L., Siew, J.W., Whitehead, S.S., Collins, P.L., and Murphy, B.R. 1997. Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology 235: 323-332.
19. Escoffier, C., Manié, S., Vincent, S., Muller, C.P., Billeter, M., and Gerlier, D. 1999. Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J. Virol. 73: 1695-1698.
20. Fuerst, T.R., Niles, E.G., Studier, F.W., and Moss, B. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 93: 11371-11377.
21. Garcin, D., Pelet, T., Calain, P., Roux, L., Curran, J., and Kolakofsky, D. 1995. A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J. 14: 6087-6094.
22. Gooding, L.R. 1992. Virus proteins that counteract host immune defenses. Cell 71: 5-7.
23. Gupta, K.C., and Patwardhan, S. 1988. ACG, the initiator codon for Sendai virus C protein. J. Biol. Chem. 263: 8553-8556.
24. Hamaguchi, M., Yoshida, T., Nishikawa, K., Naruse, H., and Nagai, Y. 1983. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 128: 105-117.
25. Hasan, M.K., Kato, A., Shioda, T., Sakai, Y., Yu, D., and Nagai, Y. 1997. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′proximal first locus. J. Gen. Virol. 78: 2813-2820.
26. He, B., Paterson, R.G., Ward, C.D., and Lamb, R.A. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237: 249-260.
27. Hoffman, M.A., and Banerjee, A.K. 1997. An infectious clone of human parainfluenza virus type 3. J. Virol. 71: 4272-4277.
28. Itoh, M., Shibuta, H., and Homma, M. 1987. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J. Gen. Virol. 68: 2939-2944.
29. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., and Nagai, Y. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16: 578-587.
30. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T., Shioda, T., and Nagai, Y. 1997. Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J. Virol. 71: 7266-7272.
31. Kato, A., Sakai, Y., Shioda, T., Kondo, T., Nakanishi, M., and Nagai, Y. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1: 569-579.
32. Kolakofsky, D., Pelet, T., Garcin, D., Hausmann, S., Curran, J., and Roux, L. 1998. Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J. Virol. 72: 891-899.
33. Kurotani, A., Kiyotani, K., Kato, A., Shioda, T., Sakai, Y., Mizumoto, K., Yoshida, T., and Nagai, Y. 1998. Sendai virus C protein are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis. Genes Cells 3: 111-124.
34. Lamb, R.A., and Choppin, P.W. 1977. The synthesis of Sendai virus polypeptides in infected cells. II. Intracellular distribution of polypeptides. Virology 81: 371-381.
35. Lamb, R.A., and Choppin, P.W. 1977. The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology 81: 382-397.
36. Lamb, R.A., and Kolakofsky, D. 1996. Paramyxoviridae: the viruses and their replication, p.1177-1204. In Fields, B.N. et al (eds), Virology, 3rd ed, Raven Press, New York.
37. Latorre, P., Cadd, T., Itoh, M., Curran, J., and Kolakofsky, D. 1998. The various Sendai virus C protein are not functionally equivalent, and exert both positive and negative effects on viral RNA accumulation during the course of infection. J. Virol. 72: 5984-5993.
38. Lawson, N.D., Stillman, E.A., Whitt, M.A., and Rose, J.K. 1995. Recombinant vesicular stomatitis virus from DNA. Proc. Natl. Acad. Sci. U.S.A. 92: 4477-4481.
39. Mebatsion, T., Finke, S., Weiland, F., and Conzelmann, K.-K. 1997. A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90: 840-847.
40. Moriya, C., Shioda, T., Tashiro, K., Nagasawa, T., Ikegawa, M., Ohnishi, Y., Kato, A., Hu, H., Xin, X., Hasan, M.K., Maekawa, M., Takebe, Y., Sakai, Y., Honjo, T., and Nagai, Y. 1998. Large quantity production with extreme convenience of human SDF-1α and SDF-1β by a Sendai virus vector. FEBS Lett. 425: 105-111.
41. Nagai, Y. 1993. Protease-dependent virus tropism and pathogenicity. Trends Microbiol. 1: 81-87.
42. Nagai, Y. 1999. Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev. Med. Virol. 9: 83-99.
43. Nagai, Y., Klenk, H.-D., and Rott, R. 1976. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72: 494-508.
44. Nagai, Y., Ogura, H., and Klenk, H.-D. 1976. Studies on the assembly of the envelope of Newcastle disease virus. Virology 69: 523-538.
45. Nagai, Y., Yoshida, T., Hamaguchi, M., Nagura, H., Hasegawa, H., Yoshimura, S., and Watanabe, K. 1983. Subcellular location of the major protein antigens of paramyxoviruses revealed by immunoperoxidase cytochemistry. Microbiol. Immunol., 27: 531-545.
46. Neumann, G., Watanabe, T., Ito, H., Watanabe, S., Goto, H., Gao, P., Hughes, M., Perez, D.R., Donis, R., Hoffmann, E., Hubom, G., and Kawaoka, Y. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. in press.
47. Palese, P., Zheng, H., Engelhardt, O.G., Pleschka, S., and Garcia-Sastre, A. 1996. Negative-strand RNA viruses: genetic engineering and applications. Proc. Natl. Acad. Sci. U.S.A. 93: 11354-11358.
48. Peeters, B.P.H., de Leeuw, O.S., Koch, G., and Gielkens, A.L.J. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73: 5001-5009.
49. Pelet, T., Curran, J., and Kolakofsky, D. 1991. The P gene of bovine parainfluenza virus 3 expresses all three reading frames from a single mRNA editing site. EMBO J. 10: 443-448.
50. Peluso, R.W., Lamb, R.A., and Choppin, P.W. 1977. Polypeptide synthesis in simian virus 5-infected cells. J. Virol. 23: 177-187.
51. Portner, A., Gupta, K.C., Seyer, J.M., Beachey, E.H., and Kingsbury, D.W. 1986. Localization and characterization of Sendai virus nonstructural C and C′ proteins by antibodies against synthetic peptides. Virus Res. 6: 109-121.
52. Radecke, F., and Billeter, M.A. 1996. The nonstructural C protein is not essential for multiplication of Edmonston B strain measles virus in cultured cells. Virology 217: 418-421.
53. Radecke, F., and Billeter, M.A. 1997. Reverse genetics meets the nonsegmented negative-strand RNA viruses. Rev. Med. Virol. 7: 49-63.
54. Radecke, F., Spielhofer, P., Schneider, H., Kaelin, K., Huber, M., Dotsch, K., Christiansen, G., and Billeter, M.A. 1995. Rescue of measles virus from cloned DNA. EMBO J. 23: 5773-5784.
55. Roberts, A., and Rose, J.K. 1998. Recovery of negative-strand RNA viruses from plasmids DNAs: a positive approach revitalizes a negative field. Virology 247: 1-6.
56. Rose, J.K. 1996. Positive strands to the rescue again: a segmented negative-strand RNA virus derived from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 94: 14998-15000.
57. Sakaguchi, T., Kiyotani, K., Kato, A., Asakawa, M., Fujii, Y., Nagai, Y., and Yoshida, T. 1997. Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 235: 360-366.
58. Schneider, H., Kaelin, K., and Billeter, M.A. 1997. Recombinant measles viruses defective for RNA editing and V protein synthesis are viable in cultured cells. Virology 227: 314-322.
59. Schnell, M.J., Johnson, J.E., Buonocore, L., and Rose, J.K. 1997. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90: 849-857.
60. Schnell, M.J., Mebatsion, T., and Conzelmann, K.-K. 1994. Infectious rabies virus from cloned cDNA. EMBO J. 13: 4195-4203.
61. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E.E., Hu, H., Kato, A., Sakai, Y., Honjo, T., Nomoto, A., Iwamoto, A., Morimoto, C., and Nagai, Y. 1998. Anti-HIV-1 and chemotactic activities of SDF-1α and SDF-1β are abolished by CD26/dipeptidyl peptidase IV mediated cleavage. Proc. Natl. Acad. Sci. U.S.A. 95: 6331-6336.
62. Skiadopoulos, M.H., Durbin, A.P., Tatem, J.M., Wu, S.L., Paschalis, A., Tao, T., Collins, P.L., and Murphy, B.R. 1998. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes. J. Virol. 72: 1762-1768.
63. Takeda, M., Kato, A., Kobune, F., Sakata, H., Li, Y., Shioda, T., Sakai, Y., Asakawa, M., and Nagai, Y. 1998. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72: 8690-8696.
64. Takeda, M., Kato, A., Sakaguchi, T., Kobune, F., Li, Y., and Nagai, Y. 1999. The genome nucleotide sequence of a contemporary wild-strain of measles virus and its comparison with the classical Edmonston strain genome. Virology 256: 340-350.
65. Tao, T., Durbin, A.P., Whitehead, S.S., Davoodi, F., Collins, P.L., and Murphy, B.R. 1998. Recovery of a fully viable chimeric human parainfluenza virus (PIV) type 3 in which the hemagglutinin-neuraminidase and fusion glycoproteins have been replaced by those of PIV type 1. J. Virol. 72: 2955-2961.
66. Thomas, S.M., Lamb, R.A., and Paterson, R.G. 1988. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54: 891-902.
67. Tober, C., Seufert, M., Schneider, H., Billeter, M.A., Johnston, I.C.D., Niewiesk, S., ter Meulen, V., and Schneider-Schaulies, S. 1998. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72: 8124-8132.
68. Toyoda, T., Sakaguchi, T., Imai, K., Inocencio, N.M., Gotoh, B., Hamaguchi, M., and Nagai, Y. 1987. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158: 242-247.
69. Valsamakis, A., Schneider, H., Auwaerter, P.G., Kaneshima, H., Billeter, M.A., and Griffin, D.E. 1998. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72: 7754-7761.
70. Vidai, S., Curran, J., and Kolakofsky, D. 1990. A stuttering model for paramyxovirus P mRNA editing. EMBO J. 9: 2017-2022.
71. Vidai, S., Curran, J., and Kolakofsky, D. 1990. Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J. Virol. 64: 239-246.
72. Whelan, S.P.J., Ball, L.A., Barr, J.N., and Wertz, G.T.W. 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. U.S.A. 92: 8388-8392.
73. Yamada, H., Hayata, S., Omata-Yamada, T., Taira, H., Mizumoto, K., and Iwasaki, K. 1990. Association of the Sendai virus C protein with nucleocapsids. Arch. Virol. 113: 245-253.
74. Yu, D., Shioda, T., Kato, A., Hasan, M. K., Sakai, Y., and Nagai, Y. 1997, Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells 2: 457-466.